Entry Detail



General Information

Database ID:exR0012353
RNA Name:RPL37
RNA Type:mRNA
Chromosome:chr5
Starnd:-
Coordinate:
Start Site(bp):40825262End Site(bp):40835222
External Links:ENSG00000145592



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC005837.2
chr17
76732978
76738522
+
AC138811.2
chr16
18788063
18801519
-
AGAP4
chr10
45825594
45853875
-
AHDC1
chr1
27534035
27604431
-
AL360181.3
chr10
133380017
133420271
+
ACTR2
chr2
65227753
65271253
+
ALDOA
chr16
30064164
30070457
+
AKR1C1
chr10
4963253
4983283
+
AC073896.1
chr12
56285916
56316059
-
AC009690.1
chr15
72284727
72375981
-
AC010422.5
chr19
12664828
12669397
-
ACTG1
chr17
81509971
81523847
-
AICDA
chr12
8602170
8612867
-
ABCC5
chr3
183919934
184017939
-
AC005258.1
chr19
2269525
2341172
+
AC018523.2
chr11
14493783
14520344
-
A1BG
chr19
58345178
58353492
-
AFTPH
chr2
64524305
64593005
+
AL590132.1
chr1
210858125
211134146
-
ACTB
chr7
5527148
5563784
-
ACKR3
chr2
236567787
236582354
+
AGO4
chr1
35808016
35857890
+
AC135050.2
chr16
31083439
31094956
-
AHCYL1
chr1
109984765
110023742
+
AKT3
chr1
243488233
243851079
-
AGAP1
chr2
235494043
236131800
+
ABHD14B
chr3
51968510
51983409
-
AKIRIN1
chr1
38991276
39006059
+
AC008750.8
chr19
51350373
51368099
-
ADIPOR2
chr12
1688574
1788674
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-302c-3p
chr4
112648366
112648388
-
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC002470.2
chr22
20979462
20998121
+
AC012313.3
chr19
58346854
58362751
-
AC113414.1
chr5
162424042
163437326
-
AC245014.3
chr1
145281116
145281462
+
AC245033.4
chr15
82533175
82540008
-
AL022311.1
chr22
37876148
37895563
+
AL132780.1
chr14
22929607
22956374
+
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.